Cargando…
Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer
Gastric cancer is a leading cause of cancer worldwide. Our previous studies showed that aberrant activation of JAK/STAT3 signaling confer epigenetically silences STAT3 target genes in gastric cancer. To further investigate the clinical significance of this phenomenon, we performed Illumina 850K meth...
Autores principales: | Wei, Kuo-Liang, Chou, Jian-Liang, Chen, Yin-Chen, Jin, Hongchuan, Chuang, Yu-Min, Wu, Cheng-Shyong, Chan, Michael W. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564691/ https://www.ncbi.nlm.nih.gov/pubmed/31194837 http://dx.doi.org/10.1371/journal.pone.0218338 |
Ejemplares similares
-
Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers
por: Tran, Mita T. M. T., et al.
Publicado: (2021) -
Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer
por: Wei, Kuo-Liang, et al.
Publicado: (2021) -
Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer
por: Wu, Cheng-Shyong, et al.
Publicado: (2016) -
Methylation Heterogeneity and Gene Expression of SPG20 in Solid Tumors
por: Cusenza, Vincenza Ylenia, et al.
Publicado: (2022) -
An integrated modelling methodology for estimating global incidence and prevalence of hereditary spastic paraplegia subtypes SPG4, SPG7, SPG11, and SPG15
por: Vander Stichele, Geert, et al.
Publicado: (2022)